Bruno Bockorny

17PUBLICATIONS
194CO-AUTHORS
Molecular targetsMedical genetics (excl. cancer genetics)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 23, 2026
Acquired TSC1 Mutation as a Mechanism of Alectinib Resistance in ALK-Fused Leiomyosarcoma: Response to Combined ALK and Mammalian Target of Rapamycin Inhibition.

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|May 12, 2026
A Multicenter Retrospective Outcomes Analysis of Patients with Localized Synovial Sarcoma.

|Apr 20, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Jan 13, 2026
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.

Timothy A Yap, Randy F Sweis, Ulka Vaishampayan

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

Pageof 3

Frequent Collaborators

3 joint publications

Manuel Hidalgo

3 joint publications

Joseph E Grossman

3 joint publications

Benjamin Schlechter

3 joint publications

Andrea J Bullock